Skip to main content
ENANTA PHARMACEUTICALS INC logo

ENANTA PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · ENTA ISIN · US29251M1062 LEI · 529900SSN4DODDQSN594 US Manufacturing
Filings indexed 812 across all filing types
Latest filing 2025-02-14 Director's Dealing
Country US United States of America
Listing US ENTA

About ENANTA PHARMACEUTICALS INC

https://www.enanta.com/

Enanta Pharmaceuticals is a clinical-stage biotechnology company that discovers and develops small molecule drugs, with a focus on virology and immunology. The company utilizes a robust, chemistry-driven approach to create novel oral therapeutics for diseases with high unmet medical needs. Enanta has a significant track record of success, having developed protease inhibitors that are key components of treatment regimens for chronic hepatitis C virus (HCV) infection, which have cured over one million patients. Its current clinical pipeline is primarily focused on developing treatments for respiratory syncytial virus (RSV) and advancing its immunology programs for inflammatory diseases.

Recent filings

Filing Released Lang Actions
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2025-02-14 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2025-02-12 English
10-Q
Interim / Quarterly Report Q1 2025
2025-02-12 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-02-11 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated February 10, 2025, reporting the results of operations for the fiscal quarter ended December 31, 2024. It specifically mentions that the company announced its quarterly financial results via a press release incorporated as an exhibit. The document itself is a current report providing an update on quarterly financial results, which aligns with the definition of an Earnings Release (ER) as it contains key highlights of quarterly financial performance. The document length is 3159 characters, which is short but contains the actual announcement of quarterly results, not just a notice of report publication. Therefore, the appropriate classification is Earnings Release (ER).
2025-02-10 English
ARS
Annual Report
2025-01-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.